Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

5.9K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
5.9K
Combined Effects of Drugs: Synergism01:27

Combined Effects of Drugs: Synergism

6.7K
Synergism is a useful mechanism where combining two or more drugs is more effective than each constituent used alone. Such combinations are also called supra-additive interactions. The drugs collectively enhance the final therapeutic effect by acting on different targets. Another advantage is that the low dose of each constituent drug is sufficient to achieve the desired effect. This helps reduce the duration of therapy and lower the adverse effects of these drugs.
Such synergistic combinations...
6.7K
Structure-Activity Relationships and Drug Design01:28

Structure-Activity Relationships and Drug Design

1.7K
Drug design is a dynamic field that involves discovering and developing new medications based on specific biological targets. This process heavily relies on structure-activity relationships (SAR) and quantitative structure-activity relationships (QSAR) to guide the design and optimization of efficient drugs.
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
1.7K
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

8.6K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
8.6K
Adaptive Mechanisms in Cancer Cells02:53

Adaptive Mechanisms in Cancer Cells

6.9K
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
6.9K
Agonism and Antagonism: Quantification01:14

Agonism and Antagonism: Quantification

975
When drugs are administered, they can elicit either an agonist or antagonist effect on the body. Agonism occurs when a drug activates a specific receptor, triggering a biological response. On the other hand, antagonism happens when a drug binds to the same receptors but blocks their activation, thereby preventing a biological response.
To quantify these effects, researchers use a dose-response curve, which provides valuable information about the potency and efficacy of a drug. Potency refers to...
975

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Protocol for a digital health-assisted cluster randomised controlled trial to prevent obesity in preschool children in Jinan, China.

BMJ open·2026
Same author

Swarm Intelligence in Drug Discovery Applications: Unlocking Deeper Insights on the Identification and Optimization of Potential Drug Candidates.

Drug design, development and therapy·2026
Same author

5-Methoxyflavone suppresses nasopharyngeal carcinoma proliferation through regulating p53/SREBP/SCD signaling-mediated lipid synthesis and ferroptosis.

BMC biotechnology·2026
Same author

DSH_YOLO enables factory farming production: a method for detecting and grading the cumulative internode length of tomato seedlings.

Frontiers in plant science·2026
Same author

AF-RT-DETR: Adaptive cross-scale feature interaction for real-time plant disease detection in complex field environments.

Frontiers in plant science·2026
Same author

A pipeline towards missing IS-A relationship discovery in the Gene Ontology.

Journal of biomedical informatics·2026

Related Experiment Video

Updated: Jan 15, 2026

Diagonal Method to Measure Synergy Among Any Number of Drugs
12:08

Diagonal Method to Measure Synergy Among Any Number of Drugs

Published on: June 21, 2018

19.5K

GLA-Synergy: An Interpretable Global-Local Adaptive Framework for Drug Synergy Prediction in Cancer Treatment.

Lizhi Deng1, Shiyu Yan1, Jiaoxing Yang2

  • 1School of Computer, University of South China, West Changsheng Road, Hengyang, Hunan 421001, China.

Journal of Chemical Information and Modeling
|October 10, 2025
PubMed
Summary

Predicting anticancer drug synergy is complex. A new deep learning model, GLA-Synergy, improves accuracy and interpretability by capturing global and local drug-cell interactions for better cancer therapy discovery.

More Related Videos

High-throughput Identification of Synergistic Drug Combinations by the Overlap2 Method
07:51

High-throughput Identification of Synergistic Drug Combinations by the Overlap2 Method

Published on: May 21, 2018

12.5K
Potentiation of Anticancer Antibody Efficacy by Antineoplastic Drugs: Detection of Antibody-drug Synergism Using the Combination Index Equation
15:04

Potentiation of Anticancer Antibody Efficacy by Antineoplastic Drugs: Detection of Antibody-drug Synergism Using the Combination Index Equation

Published on: January 19, 2019

12.7K

Related Experiment Videos

Last Updated: Jan 15, 2026

Diagonal Method to Measure Synergy Among Any Number of Drugs
12:08

Diagonal Method to Measure Synergy Among Any Number of Drugs

Published on: June 21, 2018

19.5K
High-throughput Identification of Synergistic Drug Combinations by the Overlap2 Method
07:51

High-throughput Identification of Synergistic Drug Combinations by the Overlap2 Method

Published on: May 21, 2018

12.5K
Potentiation of Anticancer Antibody Efficacy by Antineoplastic Drugs: Detection of Antibody-drug Synergism Using the Combination Index Equation
15:04

Potentiation of Anticancer Antibody Efficacy by Antineoplastic Drugs: Detection of Antibody-drug Synergism Using the Combination Index Equation

Published on: January 19, 2019

12.7K

Area of Science:

  • Computational biology
  • Drug discovery
  • Artificial intelligence in medicine

Background:

  • Predicting anticancer drug synergy is vital but challenging due to complex biological interactions.
  • Existing methods struggle to integrate multimodal features and model hierarchical drug-cell interactions.
  • Uncovering the mechanisms of drug synergy is limited by current predictive models.

Purpose of the Study:

  • To propose a novel deep learning framework, GLA-Synergy, for enhanced accuracy and interpretability in drug synergy prediction.
  • To address limitations in integrating multimodal features and modeling hierarchical interactions.
  • To provide an efficient and interpretable tool for discovering synergistic anticancer therapies.

Main Methods:

  • GLA-Synergy utilizes a multimodule architecture for global feature extraction from drugs and cell lines.
  • An improved linear attention mechanism captures local pairwise interactions.
  • Graph convolutional networks, adaptive attention, and dual bilinear attention networks are employed for feature representation and interaction learning.

Main Results:

  • GLA-Synergy consistently outperforms existing methods on multiple benchmark datasets.
  • The model demonstrates improved accuracy in predicting drug synergy.
  • The framework provides enhanced interpretability of synergistic interactions.

Conclusions:

  • GLA-Synergy offers a powerful and interpretable approach to predicting anticancer drug synergy.
  • The progressive global-local fusion framework effectively captures critical drug-cell interactions.
  • This model facilitates the discovery of novel synergistic anticancer drug combinations.